AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Genes & Diseases Article
PDF (1.3 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

EZH2 is a prognostic factor associated with tumor stemness and immune infiltration in skull base chordoma

Qian Liua,b,1, Mingxuan Lib,1, Yujia Xionga,1, Yutao Shena, Tianshun Maa, Tianhao Zhanga, Xiaohong R. Yangc, Yazhuo Zhanga,b( ), Jiwei Baia,b( )
Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD 20892, USA

Peer review under responsibility of Chongqing Medical University.

1 These authors contributed equally to this work.

Show Author Information

References

1

Duan R, Du W, Guo W. EZH2: a novel target for cancer treatment. J Hematol Oncol. 2020;13(1):104.
Crossref Google Scholar
2

Peng D, Kryczek I, Nagarsheth N, et al. Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy. Nature. 2015;527(7577):249-253.
Crossref Google Scholar
3

Yin Y, Qiu S, Li X, Huang B, Xu Y, Peng Y. EZH2 suppression in glioblastoma shifts microglia toward M1 phenotype in tumor microenvironment. J Neuroinflammation. 2017;14(1):220.
Crossref Google Scholar
4

Bai J, Shi J, Zhang Y, et al. Gene expression profiling identifies two chordoma subtypes associated with distinct molecular mechanisms and clinical outcomes. Clin Cancer Res. 2023;29(1):261-270.
Crossref Google Scholar
5

Bai J, Shi J, Li C, et al. Whole genome sequencing of skull-base chordoma reveals genomic alterations associated with recurrence and chordoma-specific survival. Nat Commun. 2021;12:757.
Crossref Google Scholar
Genes & Diseases
Volume 11 Issue 5,
September 2024
Article number: 101133
DOI: 10.1016/j.gendis.2023.101133
Cite this article:
Liu Q, Li M, Xiong Y, et al. EZH2 is a prognostic factor associated with tumor stemness and immune infiltration in skull base chordoma. Genes & Diseases, 2024, 11(5): 101133. https://doi.org/10.1016/j.gendis.2023.101133

145

Views

0

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Altmetrics
Received: 21 May 2023
Published: 11 October 2023
© 2023 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Return